Feature

Scaling Vision Innovation

Rob Scott, Vice President of Intraocular Devices R&D, Alcon

  • March 16, 2026

  • 3 min

Share

The demand for eye care is substantial, with millions affected by conditions like uncorrected refractive errors, presbyopia, and cataracts. Alcon focuses on advancing patient outcomes through innovative implantable technologies, particularly in presbyopia-correcting intraocular lenses (IOLs) such as PanOptix and Clareon. Their development process includes extensive feedback from healthcare professionals to refine surgical instruments and enhance workflows. The future of ophthalmology appears promising, with anticipated innovations in AI, robotics, and advanced IOL technology.

Original Source(s)

Scaling Vision Innovation

  • March 16, 2026

Related Content

Scaling Diabetic Eye Care in Vietnam

Orbis and Roche launch major diabetic eye care initiative in the country

  • March 17, 2026

  • 2 min
ZEISS Unveils Collaborative Care Platform

New cloud-based app aims to strengthen continuity of care across ophthalmology and optometry

  • March 17, 2026

  • 2 min
Drivers of Change: The Ophthalmologist Power List 2026

Who are the ophthalmology leaders and influencers whose achievements have advanced the field in the last 12-18 months?

  • March 16, 2026

  • 1 min